Amphastar

Nov 07, 2019

•

Sep 30, 2019

Amphastar Q3 2019 Earnings Report

Total Revenue

$80.1M

Previous year: $75.5M

Previous year: $29.3M

+20.5%

Cash and Equivalents

$85.6M

Previous year: $68.7M

+24.6%

Free Cash Flow

-$20.7M

Previous year: $3.15M

Amphastar

Unlock previous datapoints

Upgrade

Amphastar

Unlock previous datapoints

Upgrade

Revenue by Segment

Primatene MIST® Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Epinephrine Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Lidocaine Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Amphastar

Products

Get in Touch

Resources

Amphastar

Amphastar Q3 2019 Earnings Report

Amphastar

Amphastar

Revenue by Segment

Primatene MIST® Revenue

Epinephrine Revenue

Lidocaine Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Amphastar Revenue by Segment